Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Medical Device Regulatory Submissions in 2026: 510(k), De Novo, PMA, eSTAR, and FDA Approval Guide

Explore how FDA medical device submissions work across 510(k), De Novo, PMA, and eSTAR pathways. Learn how classification, predicate strategy, evidence planning, substantial equivalence, and quality documentation can support smoother premarket review and stronger regulatory readiness.
  • Blog, Medical Devices
Medical device premarket submission workflow showing eSTAR submission, predicate device comparison, substantial equivalence, and FDA premarket review.

US Pharmacopeia in 2026: USP–NF Standards, Monographs, General Chapters, and Pharmaceutical Compliance

Explore how USP-NF standards, monographs, General Chapters, and reference standards support pharmaceutical quality testing and GMP compliance. Learn which compendial requirements are mandatory, how teams manage updates, and what evidence laboratories should maintain for inspection readiness.
  • Blog, Quality Management System
Pharmaceutical quality laboratory applying USP monographs, reference standards, analytical testing, and GMP compliance controls.

USP 797 Compliance in 2026: Sterile Compounding Requirements, Cleanrooms, Training, and Inspection Readiness

Explore current USP 797 requirements for sterile compounding, cleanroom controls, personnel training, environmental monitoring, aseptic technique, and beyond-use dates. Learn how pharmacy and quality teams can strengthen inspection readiness and maintain reliable control over compounded sterile preparations.
  • Blog, Validation and Qualification
Sterile compounding technician performing aseptic technique inside a controlled cleanroom with environmental monitoring systems.

ISO 9000 in Pharma Industry in 2026: QMS Principles, ISO 9001, GMP Alignment and Implementation Guide

Explore how ISO 9000 principles support pharmaceutical quality systems, strengthen GMP compliance, and connect with ISO 9001 and ICH Q10. Learn how quality teams can apply process-based management, risk-based decisions, and continual improvement to build inspection-ready operations.
  • Blog, Quality Management System
Pharmaceutical quality management system showing GMP compliance, process approach, quality controls, and continual improvement across regulated manufacturing operations.

ISO 9001 in Pharma Industry in 2026: Requirements, GMP Compliance, ICH Q10, and Certification Guide

Explore how ISO 9001 certification supports pharmaceutical quality management, complements GMP compliance and ICH Q10, and strengthens risk management, CAPA, documentation, and continual improvement. Learn what auditors review and which evidence matters most during quality-system assessments.
  • Blog, Quality Management System
Pharmaceutical quality management system showing GMP compliance, quality risk management, CAPA, and inspection-ready documentation.

ICH Guidelines for Pharmacovigilance in 2026: E2A–E2F, ICSR Reporting, PBRER, and Risk Management

Explore how the ICH E2 series connects expedited safety reporting, electronic ICSR transmission, PBRERs, DSURs, and pharmacovigilance planning. This guide also explains regional implementation, inspection evidence, and the controls needed to maintain reliable safety operations.
  • Blog, Quality Management System
Pharmaceutical compliance dashboard showing ICH E2B R3 data exchange, individual case safety reports, periodic benefit-risk evaluation, DSUR preparation, and inspection evidence.

ICSR in Pharmacovigilance in 2026: Case Processing, E2B(R3), Reporting Timelines, and Compliance Guide

Explore how safety teams manage ICSR validity, day zero, MedDRA coding, seriousness assessment, E2B(R3) reporting, follow-up, and duplicate cases. This guide also explains reporting timelines, inspection evidence, and the controls needed for reliable pharmacovigilance compliance.
  • Blog, Quality Management System
Pharmacovigilance dashboard showing ICSR validity criteria, seriousness assessment, duplicate case management, reporting timelines, and EudraVigilance submission controls.

Pharmacovigilance System Master File in 2026: PSMF Requirements, EU GVP Module II, QPPV, and Inspection Readiness

Explore PSMF requirements, structure, maintenance, and inspection readiness under EU GVP Module II. This article explains QPPV responsibilities, annex control, computerised systems, audit evidence, and change management practices that help drug safety teams prepare for regulatory inspections.
  • Blog, Quality Management System
PSMF structure showing QPPV responsibilities, safety data systems, PSMF annexes, quality controls, audits, and inspection-ready documentation.

Medical Device Registration in Europe in 2026: EU MDR, CE Marking, EUDAMED, and Market Access Guide

Explore the EU regulatory pathway for medical devices, including classification, conformity assessment, CE marking, EUDAMED registration, UDI controls, and notified body review. Learn which records reviewers cross-check and how manufacturers can maintain EU MDR compliance after market entry.
  • Blog, Medical Devices
Medical device compliance workflow showing CE marking, technical documentation, Unique Device Identification UDI, notified body review, and EUDAMED registration in the European Union.

Medical Devices Registration in India in 2026: CDSCO Requirements and Approval Guide

Explore the CDSCO medical device registration pathway, including risk classification, Indian Authorized Agent requirements, Form MD-14 and Form MD-15, technical dossier preparation, common approval delays, and inspection-ready evidence under the Medical Devices Rules 2017.
  • Blog, Medical Devices
Medical device registration process in India showing CDSCO review, technical documentation, medical device classification in India, and regulatory approval requirements.